Pfizer Inc. (NYSE:PFE) Logo

Evercore Wealth Management Llc decreased its stake in Pfizer Inc (PFE) by 5.56% based on its latest 2018Q3 regulatory filing with the SEC. Evercore Wealth Management Llc sold 20,166 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 342,239 shares of the health care company at the end of 2018Q3, valued at $15.08 million, down from 362,405 at the end of the previous reported quarter. Evercore Wealth Management Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $245.84 billion market cap company. The stock increased 0.14% or $0.06 during the last trading session, reaching $42.53. About 36.64M shares traded or 44.57% up from the average. Pfizer Inc. (NYSE:PFE) has risen 25.07% since January 21, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 07/05/2018 – PFIZER INDIA TO PAY DIVIDEND OF 20 RUPEES/SHARE; 14/03/2018 – Global Acromegaly and Gigantism Drugs Market 2018-2022 – Key Vendors are lpsen, Novartis & Pfizer – ResearchAndMarkets.com; 10/04/2018 – Pfizer Signs Lease for the Spiral at Hudson Yards in Manhattan; 30/05/2018 – U.S. FDA SAYS EXPANDED APPROVAL OF XELJANZ (TOFACITINIB) TO INCLUDE ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS; 27/03/2018 – GSK says very confident about consumer margin goal of at least 20 pct; 05/03/2018 – ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-lnfected With Tuberculosis; 17/04/2018 – MERCK – SECOND PHASE 3 STUDY TO EVALUATE PCV-15 FOLLOWED BY PNEUMOCOCCAL VACCINE POLYVALENT GIVEN 8 WEEKS LATER IN ADULTS INFECTED WITH HIV; 17/04/2018 – Canada seeks U.S. help to solve EpiPen shortage; 29/05/2018 – PFIZER’S XALKORI® (CRIZOTINIB) GETS BREAKTHROUGH DESIGNATION IN; 09/04/2018 – NY Warn Notices: 4 / 9 / 2018 – Pfizer, Inc. – North Country Region

Wealthtrust Axiom Llc increased its stake in Tetra Technologies Inc Del (TTI) by 34.15% based on its latest 2018Q3 regulatory filing with the SEC. Wealthtrust Axiom Llc bought 161,150 shares as the company’s stock declined 54.99% with the market. The institutional investor held 633,070 shares of the energy company at the end of 2018Q3, valued at $2.86 million, up from 471,920 at the end of the previous reported quarter. Wealthtrust Axiom Llc who had been investing in Tetra Technologies Inc Del for a number of months, seems to be bullish on the $292.90 million market cap company. The stock increased 3.10% or $0.07 during the last trading session, reaching $2.33. About 704,707 shares traded. TETRA Technologies, Inc. (NYSE:TTI) has declined 49.61% since January 21, 2018 and is downtrending. It has underperformed by 49.61% the S&P500. Some Historical TTI News: 24/04/2018 – TETRA BIO PHARMA-WILL BE ELIGIBLE TO RECEIVE CERTAIN MILESTONE PAYMENTS & AN UNDISCLOSED PERCENTAGE OF SALES OF PPP001 GENERATED BY KAMADA IN ISRAEL; 24/04/2018 – TETRA BIO PHARMA-UNDER TERMS OF ANTICIPATED FINAL AGREEMENT, KAMADA WILL BE RESPONSIBLE FOR REGISTERING PRODUCT, MARKETING & DISTRIBUTION, IN ISRAEL; 14/03/2018 – RadioResource: Spanish Operator Transitions to Updated TETRA Network for Public Safety; 12/04/2018 – RadioResource: Motorola Solutions Details TETRA Network Supporting Gold Coast Games; 11/05/2018 – Mondrian Adds Tetra Tech, Exits Crown Holdings: 13F; 22/05/2018 – Tetra Technologies Presenting at JPMorgan Conference Jun 18; 03/04/2018 – FDA Grants Orphan Drug Designation for Tetra Discovery Partners’ BPN14770 for the Treatment of Fragile X Syndrome; 10/04/2018 – Tetra Bio-Pharma Announces the appointment of Gregory Drohan to its board of directors; 24/04/2018 – TETRA BIO PHARMA INC – SIGNING OF A DEFINITIVE DISTRIBUTION AGREEMENT WITH KAMADA IS EXPECTED TO FOLLOW SHORTLY; 24/04/2018 – TETRA BIO PHARMA – CO TO BE ELIGIBLE TO RECEIVE CERTAIN MILESTONE PAYMENTS, UNDISCLOSED PERCENTAGE OF SALES OF PPP001 GENERATED BY KAMADA IN ISRAEL

More important recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “Pfizer (PFE) Enters Collaboration Agreement with CytoReason – StreetInsider.com” on January 07, 2019, also Streetinsider.com published article titled: “Pfizer (PFE) Reports FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy – StreetInsider.com”, Seekingalpha.com published: “Pfizer to shutter two plants in India – Seeking Alpha” on January 09, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) was released by: Investorplace.com and their article: “Should You Buy PFE Stock on Pfizer’s Joint Venture With Glaxo? – Investorplace.com” with publication date: December 26, 2018.

Investors sentiment increased to 0.85 in Q3 2018. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Biltmore Wealth Management Llc holds 19,280 shares or 0.7% of its portfolio. Financial Pro, Texas-based fund reported 6,085 shares. 83,780 were reported by Focused Wealth Mgmt. Halsey Assoc Ct holds 25,874 shares. Sfe Invest Counsel holds 0.66% or 38,991 shares in its portfolio. New England Private Wealth Advsrs Lc has 0.19% invested in Pfizer Inc. (NYSE:PFE) for 16,394 shares. Bradley Foster & Sargent Ct has 400,549 shares for 0.6% of their portfolio. Nomura Asset Management Comm Ltd stated it has 1.31M shares. Colony Grp Limited Liability Corporation accumulated 58,898 shares or 0.13% of the stock. Verity Asset Mngmt holds 0.8% in Pfizer Inc. (NYSE:PFE) or 18,309 shares. Moreover, Somerville Kurt F has 0.34% invested in Pfizer Inc. (NYSE:PFE). Northstar Asset Mgmt Limited Liability Corp stated it has 0.45% of its portfolio in Pfizer Inc. (NYSE:PFE). The New York-based Laurion Mgmt LP has invested 0% in Pfizer Inc. (NYSE:PFE). Srb invested in 13,112 shares or 0.06% of the stock. Millennium Mngmt Llc has invested 0.01% of its portfolio in Pfizer Inc. (NYSE:PFE).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 29 before the open. They expect $0.64 EPS, up 3.23% or $0.02 from last year’s $0.62 per share. PFE’s profit will be $3.70 billion for 16.61 P/E if the $0.64 EPS becomes a reality. After $0.78 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -17.95% negative EPS growth.

Since August 13, 2018, it had 0 buys, and 1 insider sale for $418,774 activity.

Among 23 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Pfizer had 89 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, March 24 by Societe Generale. Argus Research maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, November 3. Argus Research has “Buy” rating and $46 target. The firm earned “Buy” rating on Wednesday, July 29 by Argus Research. Barclays Capital downgraded the stock to “Equal-Weight” rating in Thursday, April 5 report. The rating was maintained by Morgan Stanley with “Neutral” on Friday, April 7. The firm has “Market Perform” rating given on Thursday, November 1 by BMO Capital Markets. The firm has “Hold” rating given on Thursday, October 26 by Jefferies. Argus Research downgraded the stock to “Hold” rating in Wednesday, November 2 report. The stock of Pfizer Inc. (NYSE:PFE) earned “Equal-Weight” rating by Barclays Capital on Tuesday, December 1. Piper Jaffray maintained the stock with “Overweight” rating in Friday, August 28 report.

Evercore Wealth Management Llc, which manages about $4.87 billion and $3.13 billion US Long portfolio, upped its stake in Ishares Tr (DVY) by 5,098 shares to 26,164 shares, valued at $2.61M in 2018Q3, according to the filing. It also increased its holding in Dominos Pizza Inc (NYSE:DPZ) by 8,939 shares in the quarter, for a total of 136,659 shares, and has risen its stake in Disney Walt Co (NYSE:DIS).

More important recent TETRA Technologies, Inc. (NYSE:TTI) news were published by: Seekingalpha.com which released: “Tetra Technologies: Raising My Price Target – Seeking Alpha” on August 19, 2018, also Seekingalpha.com published article titled: “Tetra Technologies: Stock To Rise On Growth And Low Valuation – Seeking Alpha”, Investingnews.com published: “Lithium Extraction Technology Unlocking Value in the US – Investing News Network” on January 16, 2019. More interesting news about TETRA Technologies, Inc. (NYSE:TTI) was released by: Gurufocus.com and their article: “TETRA Technologies, Inc. Announces Appointment of Brady M. Murphy as a Director – GuruFocus.com” with publication date: December 26, 2018.

Wealthtrust Axiom Llc, which manages about $614.70M and $296.31 million US Long portfolio, decreased its stake in Nutrien Ltd by 32,046 shares to 62,041 shares, valued at $3.58M in 2018Q3, according to the filing.

Among 18 analysts covering Tetra Technologies (NYSE:TTI), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Tetra Technologies has $12 highest and $3.25 lowest target. $6.47’s average target is 177.68% above currents $2.33 stock price. Tetra Technologies had 48 analyst reports since August 10, 2015 according to SRatingsIntel. Wunderlich maintained the shares of TTI in report on Monday, November 9 with “Buy” rating. The company was maintained on Friday, November 10 by Loop Capital. The rating was upgraded by Credit Suisse on Wednesday, June 1 to “Outperform”. On Thursday, April 13 the stock rating was upgraded by Johnson Rice to “Buy”. The firm has “Hold” rating given on Thursday, August 13 by Zacks. The stock has “Market Perform” rating by Raymond James on Thursday, December 13. Howard Weil upgraded TETRA Technologies, Inc. (NYSE:TTI) rating on Wednesday, November 16. Howard Weil has “Sector Outperform” rating and $8 target. RBC Capital Markets downgraded the shares of TTI in report on Friday, December 16 to “Sector Perform” rating. The firm has “Equal-Weight” rating given on Wednesday, November 15 by Morgan Stanley. RBC Capital Markets maintained the shares of TTI in report on Thursday, November 9 with “Hold” rating.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart




Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *